Alendronate Increases Bone Density and Bone Strength at the Distal Radius in Postmenopausal Women
Open Access
- 1 August 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 14 (8) , 1387-1393
- https://doi.org/10.1359/jbmr.1999.14.8.1387
Abstract
In addition to the alendronate Osteoporosis Intervention Trial (FOSIT) core protocol 901–0A of 1908 enrolled patients, the use of peripheral quantitative computed tomography (pQCT) was explored for the assessment of response to therapy. Bone mineral and strength related parameters at two different sites at the distal radius were explored in a subset of the multicenter core study. One hundred and three patients were entered into the substudy and given either a daily dose of 10 mg of alendronate or placebo for 1 year. Measurements were done at months 0, 3, 6, and 12. Inclusion criteria were bone mineral density (BMD) measurements at the lumbar spine of −2 SD. The response to therapy was assessed by dual‐energy X‐ray absorptiometry in the lumbar spine and the hip, and by pQCT in the ultradistal and the shaft sites of the radius. In line with the FOSIT core study, alendronate increased BMD at the lumbar spine and the hip, and it decreased the serum biochemical markers of bone turnover. The substudy showed differences between the therapy and placebo group in trabecular bone density (8.4%, p = 0.095), in total density (6.8%, p = 0.009), and in the bone strength index (BSI) (15.6 mm3, p = 0.037) at the ultradistal site due to treatment and no changes at the radius shaft. A significant correlation was observed between percentage changes from baseline in BMD of the lumbar spine, and in total density and bone strength at the ultradistal radius site in the treatment group, but not in the placebo group. Thus, the ultradistal radius site did respond to alendronate therapy. The increased bone density accompanied a significant gain in the BSI at the ultradistal site, a finding that might help explain the reduced wrist fractures in the alendronate Fracture Intervention Trial.Keywords
This publication has 22 references indexed in Scilit:
- Prediction of fracture load at different skeletal sites by geometric properties of the cortical shellJournal of Bone and Mineral Research, 1996
- Effects of large doses of olpadronate (Dimethyl-pamidronate) on mineral density, cross-sectional architecture, and mechanical properties of rat femursBone, 1995
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO reportOsteoporosis International, 1994
- The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.Journal of Clinical Investigation, 1993
- Cross-sectional geometrical properties and bone mineral contents of the human radius and ulnaJournal of Biomechanics, 1993
- Interrelationships between densitometric, geometric, and mechanical properties of rat femora: Inferences concerning mechanical regulation of bone modelingJournal of Bone and Mineral Research, 1993
- Appendicular bone mineral and a woman's lifetime risk of hip fractureJournal of Bone and Mineral Research, 1992
- Differential effects of aging and disease on trabecular and compact bone density of the radiusBone, 1991
- Periphere quantitative Computertomographie zur Knochenmineralmessung mit einem neuen speziellen QCT-ScannerRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1991
- Predicting Femoral Neck Strength From Bone Mineral DataInvestigative Radiology, 1990